• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T 细胞介导的附加细胞毒性——多管齐下的死亡之弹。

T cell-mediated additive cytotoxicity - death by multiple bullets.

机构信息

Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University of Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.

Department of Cell Biology, RIMLS, Radboud University Medical Center, Nijmegen, The Netherlands; David H. Koch Center for Applied Research of Genitourinary Cancers, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Cancer Genomics Centre Netherlands (CGC.nl), Utrecht University, Utrecht, The Netherlands.

出版信息

Trends Cancer. 2022 Dec;8(12):980-987. doi: 10.1016/j.trecan.2022.07.007. Epub 2022 Aug 11.

DOI:10.1016/j.trecan.2022.07.007
PMID:35965200
Abstract

Immune effector cells, including cytotoxic T cells (CTLs), induce apoptosis and eliminate target cells by direct cell-cell contacts. In vivo, CTLs fail to efficiently kill solid tumor cells by individual contacts but rely upon multihit interactions by many CTLs (swarming). Recent evidence has indicated that multihit interactions by CTLs induce a series of sublethal damage events in target cells, including perforin-mediated membrane damage, induction of reactive oxygen species (ROS), nuclear envelope rupture, and DNA damage. Individual damage can be repaired, but when induced in rapid sequence, sublethal damage can accumulate and induce target cell death. Here, we summarize the sublethal damage and additive cytotoxicity concepts for CTL-induced and other cell stresses and discuss the implications for improving immunotherapy and multitargeted anticancer therapies.

摘要

免疫效应细胞,包括细胞毒性 T 细胞(CTL),通过直接的细胞-细胞接触诱导细胞凋亡并消除靶细胞。在体内,CTL 通过单个接触无法有效地杀死实体肿瘤细胞,但依赖于许多 CTL 的多击相互作用(群集)。最近的证据表明,CTL 的多击相互作用会在靶细胞中诱导一系列亚致死性损伤事件,包括穿孔素介导的膜损伤、活性氧(ROS)的诱导、核膜破裂和 DNA 损伤。单个损伤可以被修复,但是当以快速序列诱导时,亚致死性损伤可以累积并诱导靶细胞死亡。在这里,我们总结了 CTL 诱导的和其他细胞应激的亚致死性损伤和相加细胞毒性概念,并讨论了改善免疫疗法和多靶点抗癌疗法的意义。

相似文献

1
T cell-mediated additive cytotoxicity - death by multiple bullets.T 细胞介导的附加细胞毒性——多管齐下的死亡之弹。
Trends Cancer. 2022 Dec;8(12):980-987. doi: 10.1016/j.trecan.2022.07.007. Epub 2022 Aug 11.
2
Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity.细胞毒性 T 细胞能够通过附加细胞毒性有效地消除癌细胞。
Nat Commun. 2021 Sep 1;12(1):5217. doi: 10.1038/s41467-021-25282-3.
3
Cytotoxic T lymphocyte-induced killing in the absence of granzymes A and B is unique and distinct from both apoptosis and perforin-dependent lysis.在缺乏颗粒酶A和颗粒酶B的情况下,细胞毒性T淋巴细胞诱导的杀伤作用是独特的,且不同于凋亡和穿孔素依赖性裂解。
J Cell Biol. 2006 Apr 10;173(1):133-44. doi: 10.1083/jcb.200510072.
4
Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines.候选艾滋病疫苗诱导的HIV-1特异性CD4+人CTL克隆的细胞溶解机制研究。
J Immunol. 1994 Sep 15;153(6):2787-99.
5
Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.肿瘤特异性细胞毒性T淋巴细胞(CTL)在体外利用穿孔素和Fas配体介导的细胞溶解作用杀伤小鼠肾癌细胞,但在体内,在没有穿孔素的情况下也能使肿瘤消退。
J Immunol. 2002 Apr 1;168(7):3484-92. doi: 10.4049/jimmunol.168.7.3484.
6
Cloned cytotoxic T lymphocyte target cells fail to induce early activation events in effector cytotoxic T lymphocytes.克隆的细胞毒性T淋巴细胞靶细胞无法在效应细胞毒性T淋巴细胞中诱导早期激活事件。
Cell Immunol. 1988 Jun;114(1):188-97. doi: 10.1016/0008-8749(88)90265-1.
7
Myeloma cells are highly sensitive to the granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes.骨髓瘤细胞对由WT1特异性细胞毒性T淋巴细胞介导的颗粒胞吐途径高度敏感。
Clin Cancer Res. 2004 Nov 1;10(21):7402-12. doi: 10.1158/1078-0432.CCR-04-0825.
8
Targeting lymphotoxin beta receptor with tumor-specific T lymphocytes for tumor regression.利用肿瘤特异性T淋巴细胞靶向淋巴毒素β受体以实现肿瘤消退。
Clin Cancer Res. 2007 Sep 1;13(17):5202-10. doi: 10.1158/1078-0432.CCR-07-1161.
9
PELs and the perforin and granzyme independent mechanism of CTL-mediated lysis.浆细胞样淋巴瘤以及细胞毒性T淋巴细胞介导的裂解的穿孔素和颗粒酶非依赖机制。
Immunol Rev. 1995 Aug;146:21-31. doi: 10.1111/j.1600-065x.1995.tb00681.x.
10
Differential activation of the death receptor pathway in human target cells induced by cytotoxic T lymphocytes showing different kinetics of killing.细胞毒性T淋巴细胞诱导人靶细胞中死亡受体途径的差异激活,表现出不同的杀伤动力学。
Haematologica. 2007 Dec;92(12):1671-8. doi: 10.3324/haematol.11308.

引用本文的文献

1
Immunological synapse: structures, molecular mechanisms and therapeutic implications in disease.免疫突触:结构、分子机制及在疾病中的治疗意义
Signal Transduct Target Ther. 2025 Aug 11;10(1):254. doi: 10.1038/s41392-025-02332-6.
2
Time-varying stimuli that prolong IKK activation promote nuclear remodeling and mechanistic switching of NF-κB dynamics.延长IKK激活的时变刺激促进核重塑和NF-κB动力学的机制转换。
Nat Commun. 2025 Aug 8;16(1):7329. doi: 10.1038/s41467-025-62837-0.
3
Deciphering antigen-specific T cell navigation tactics and cancer immune evasion in co-cultures.
解析共培养体系中抗原特异性T细胞的导航策略及癌症免疫逃逸机制。
Commun Biol. 2025 Jul 31;8(1):1140. doi: 10.1038/s42003-025-08568-w.
4
TRPV1 inhibition sensitizes tumors to PD-1 blockade by reversing resistance to CTL-mediated killing.瞬时受体电位香草酸亚型1(TRPV1)抑制通过逆转对细胞毒性T淋巴细胞(CTL)介导杀伤的抗性,使肿瘤对程序性死亡蛋白1(PD-1)阻断敏感。
Sci Rep. 2025 Jul 1;15(1):20600. doi: 10.1038/s41598-025-07120-4.
5
New mechanistic understanding of FXR agonist Vonafexor: inducing sublethal damage of HBV-positive liver cancer cells via promoting anti-tumor immunity.法尼醇X受体激动剂沃纳法索对机制的新认识:通过促进抗肿瘤免疫诱导HBV阳性肝癌细胞的亚致死损伤。
Br J Cancer. 2025 Jun 30. doi: 10.1038/s41416-025-03089-z.
6
Optogenetic engineering for precision cancer immunotherapy.用于精准癌症免疫治疗的光遗传学工程
Trends Pharmacol Sci. 2025 Jun 10. doi: 10.1016/j.tips.2025.05.002.
7
Predictive factors for neoadjuvant combined immunotherapy in gastric adenocarcinoma: Focusing on the primitive enterocyte phenotype and PVR.胃腺癌新辅助联合免疫治疗的预测因素:聚焦原始肠上皮细胞表型和脊髓灰质炎病毒受体
Br J Cancer. 2025 May 8. doi: 10.1038/s41416-025-03031-3.
8
Mechanistic insights into resistance mechanisms to T cell engagers.对T细胞衔接器耐药机制的机制性见解。
Front Immunol. 2025 Apr 22;16:1583044. doi: 10.3389/fimmu.2025.1583044. eCollection 2025.
9
Immunocytes in the tumor microenvironment: recent updates and interconnections.肿瘤微环境中的免疫细胞:最新进展与相互联系
Front Immunol. 2025 Apr 14;16:1517959. doi: 10.3389/fimmu.2025.1517959. eCollection 2025.
10
Advances in research on flavonoids in tumor immunotherapy (Review).黄酮类化合物在肿瘤免疫治疗中的研究进展(综述)
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13515. Epub 2025 Apr 11.